| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/10/2013 | CN102319439B Drug with magnetic microspheres, and use thereof |
| 07/10/2013 | CN102266326B Imipenem and cilastatin sodium pharmaceutical composition liposome injection |
| 07/10/2013 | CN102212116B Acetylcholine receptor mediated brain-targeted polypeptide and application thereof |
| 07/10/2013 | CN102167817B Preparation method of polyamino acid and polyamino acid nano-hydrogel |
| 07/10/2013 | CN102145174B Chondroitin sulfate nano-selenium and preparation method thereof |
| 07/10/2013 | CN102139108B Co-ground materials of benzimidazoles proton pump inhibitors and hydrophilic polymer ground mixture |
| 07/10/2013 | CN102127184B Enteric medicinal coating polyacrylic resin emulsion with internal plasticization function and preparation method thereof |
| 07/10/2013 | CN102030754B Non-viral vector, and preparation method and application thereof |
| 07/10/2013 | CN101938992B Composition and method for assisting swallowing |
| 07/10/2013 | CN101926770B Drug-loaded liposome and preparation method thereof |
| 07/10/2013 | CN101835467B Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
| 07/10/2013 | CN101816777B Novel Boanmycin composition and preparation method thereof |
| 07/10/2013 | CN101810594B Production method of silybin meglumine tablets |
| 07/10/2013 | CN101810560B Cyclosporine A polymeric micelles composition |
| 07/10/2013 | CN101810559B Hirudin polyion micelle composition of targeted platelet |
| 07/10/2013 | CN101678086B 固体纤维蛋白原制剂 The solid fibrinogen preparation |
| 07/10/2013 | CN101647799B Stable artesunate amodiaquine hydrochloride compound tablet and preparation method thereof |
| 07/10/2013 | CN101588715B Material, item and products comprising a composition having anti-microbial properties |
| 07/10/2013 | CN101583380B Method for preparing a polymer conjugate |
| 07/10/2013 | CN101516334B Stabilizing compositions for antibiotics and methods of use |
| 07/10/2013 | CN101496901B Application of acidic buffer in stable pollen allergen activity |
| 07/10/2013 | CN101431984B Bioresorbable controlled-release composition |
| 07/10/2013 | CN101375846B Ellagic acid supermolecule composition and preparation method |
| 07/10/2013 | CN101247836B Nanoparticle active ingredients conjugates |
| 07/10/2013 | CN101180400B Nanoparticles comprising RNA ligands |
| 07/09/2013 | US8481493 Non-porous film for culturing cells |
| 07/09/2013 | US8481091 Pharmaceutical compositions |
| 07/09/2013 | US8481081 Mixture of water insoluble drug and polymer |
| 07/09/2013 | US8481075 Preparation and application of biodegradable-material-made microsphere vascular embolus containing liposome-encapsulated cytokines |
| 07/09/2013 | US8481073 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| 07/09/2013 | US8481072 Composition and method to alleviate joint pain |
| 07/09/2013 | US8481070 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 07/09/2013 | US8481058 Topical composition, topical composition precursor, and methods for manufacturing and using |
| 07/09/2013 | US8481003 Anti-CD74 immunoconjugates and methods |
| 07/09/2013 | US8481000 Thickened beverages for dysphagia |
| 07/09/2013 | US8480952 Method of manufacturing pharmaceutical preparations containing liposomes |
| 07/09/2013 | CA2700356C Sol-gel phase-reversible hydrogel templates and uses thereof |
| 07/09/2013 | CA2648936C Glp-1 compounds |
| 07/09/2013 | CA2640331C Stabilized pharmaceutical composition |
| 07/09/2013 | CA2598353C Non-fibrous transdermal therapeutic system and method for its production |
| 07/09/2013 | CA2566931C Tablets exhibiting reduced drug release variability |
| 07/09/2013 | CA2563739C Bioavailable solid dosage forms of metaxalone |
| 07/09/2013 | CA2558583C Polymer-based compositions and conjugates of hiv entry inhibitors |
| 07/09/2013 | CA2537290C Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 07/09/2013 | CA2533314C Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| 07/09/2013 | CA2512824C Improved oral delivery of peptides |
| 07/09/2013 | CA2445565C Compositions and methods of double-targeting virus infections and cancer cells |
| 07/06/2013 | CA2771564A1 Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells |
| 07/04/2013 | WO2013101749A1 Stabilized glucagon nanoemulsions |
| 07/04/2013 | WO2013101712A1 Degradable composite materials and uses |
| 07/04/2013 | WO2013100882A2 Combinations of diacerein and non-steroidal inflammation drugs |
| 07/04/2013 | WO2013100881A2 Combined pharmaceutical formulation containing diacerein |
| 07/04/2013 | WO2013100715A1 IN SITU CROSSLINKING HYDROGEL COMPRISING γ-POLYGLUTAMIC ACID AND METHOD FOR PRODUCING THE SAME |
| 07/04/2013 | WO2013100705A1 Fast-disintegrating tablet suitable for environmentally sensitive drug and process for manufacturing the same |
| 07/04/2013 | WO2013100704A1 A site-specific glp-2 conjugate using an immunoglobulin fragment |
| 07/04/2013 | WO2013100701A1 Highly robust fast-disintegrating tablet and process for manufacturing the same |
| 07/04/2013 | WO2013100204A1 Pharmaceutical preparation comprising brexpiprazole and substituted beta - cyclodextrin |
| 07/04/2013 | WO2013098841A1 Nanodispersion of poorly water soluble drug(s) |
| 07/04/2013 | WO2013098813A1 Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents |
| 07/04/2013 | WO2013098675A1 Compositions for the treatment of mucous membrane diseases |
| 07/04/2013 | WO2013098408A1 Glucagon and cck receptor agonist peptide conjugates |
| 07/04/2013 | WO2013075066A3 Variant serum albumin with improved half -life and other properties |
| 07/04/2013 | WO2013056250A3 Cxcr4 inhibiting carriers for nucleic acid delivery |
| 07/04/2013 | WO2013050617A9 Structured polypeptides with sarcosine linkers |
| 07/04/2013 | WO2013032828A8 Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
| 07/04/2013 | WO2013028049A3 Composition for the percutaneous administration of active compounds providing a suitable treatment for androgenetic alopecia |
| 07/04/2013 | WO2013019733A4 Methods, compositions and kits for therapeutic treatment with wet spun microstructures |
| 07/04/2013 | WO2013019669A3 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses |
| 07/04/2013 | WO2013014538A3 Single-domain antibodies and graphene coated magnetic metal nanoparticles conjugate and methods for using the same |
| 07/04/2013 | WO2012003562A8 Antineoplastic pharmaceutical compositions containing substituted nitroimidazoles |
| 07/04/2013 | US20130172428 High enhancer-loading polyacrylate formulation for transdermal applications |
| 07/04/2013 | US20130172422 Desensitizing drug product |
| 07/04/2013 | US20130172404 Delivery of Oligonucleotide Functionalized Nanoparticles |
| 07/04/2013 | US20130172382 Abuse-resistant controlled-release opioid dosage form |
| 07/04/2013 | US20130172375 Pharmaceutical composition |
| 07/04/2013 | US20130172374 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof |
| 07/04/2013 | US20130172307 5a-ANDROSTANE (ALKYL)-3b, 5, 6b-TRIOL INJECTION AND PREPARATION METHOD THEREFOR |
| 07/04/2013 | US20130172274 Methods and compositions for delivering active agents with enhanced pharmacological properties |
| 07/04/2013 | US20130172266 Mitochondrial penetrating peptides as carriers for anticancer compounds |
| 07/04/2013 | US20130172260 Prevention of indwelling device related infection: composition and methods |
| 07/04/2013 | US20130172251 Modified ghrelin peptides |
| 07/04/2013 | US20130172234 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 07/04/2013 | US20130172230 Treating Stroke and Other Diseases Without Inhibiting N-Type Calcium Channels |
| 07/04/2013 | US20130172229 Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences |
| 07/04/2013 | US20130171248 Oral formulation for delivery of poorly absorbed drugs |
| 07/04/2013 | US20130171240 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 07/04/2013 | US20130171212 Stable Aqueous Formulations Comprising Poorly Water Soluble Active Ingredients |
| 07/04/2013 | US20130171208 Compositions of nanoparticles and methods of making the same |
| 07/04/2013 | US20130171197 Hyaluronic acid hydrogel and use thereof |
| 07/04/2013 | US20130171179 Recombinant t-cell receptor ligands with covalently bound peptides |
| 07/04/2013 | US20130171175 Factor IX Polypeptides and Methods of Use Thereof |
| 07/04/2013 | US20130171129 Constrained immunogenic compositions and uses therefor |
| 07/04/2013 | US20130171128 Reducing viscosity of pharmaceutical formulations |
| 07/04/2013 | US20130171126 Crosslinked polysaccharide beads and their biomedical uses |
| 07/04/2013 | US20130171074 Targeting compounds |
| 07/04/2013 | US20130171064 Anti-CD74 Immunoconjugates and Methods of Use |
| 07/04/2013 | CA2858336A1 Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents |
| 07/04/2013 | CA2857043A1 Silicone-based composition for skin treatment |
| 07/04/2013 | CA2854281A1 A muscle atrophy inhibitor |
| 07/03/2013 | EP2609935A1 Switching fluorescent nanoparticle probe and fluorescent particle imaging method using same |